Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Acorn Bioventures

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA
  • Canada
Investment stages
  • Seed
Industries
  • Pharmaceuticals
  • Biotechnology
  • Medical Devices
About
Acorn Bioventures invests across stages in small cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Their investment flexibility allows them to provide value across the entire spectrum from seed financing to public markets.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

They Invest in early to growthstage biotechnology companies, focusing on transformative therapies and innovative healthcare solutions.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Anacor

Arena

Ascendis

Bicara

BioAtla

Cardiff Oncology

CG Oncology

Eidos

GW Pharma

Neuron23

OnKure

Q32 Bio

Tesaro

Urogen

Y-mAbs

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp